Provided by Tiger Trade Technology Pte. Ltd.

Fennec Pharmaceuticals Inc.

11.38
+0.09000.80%
Volume:63.45K
Turnover:708.28K
Market Cap:399.06M
PE:-94.83
High:11.47
Open:11.25
Low:10.88
Close:11.29
52wk High:13.25
52wk Low:5.65
Shares:35.07M
Float Shares:19.78M
Volume Ratio:0.81
T/O Rate:0.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1200
EPS(LYR):-0.3409
ROE:-18.58%
ROA:-1.16%
PB:9.40
PE(LYR):-33.39

Loading ...

Fennec Pharmaceuticals Publishes Corporate Presentation Highlighting Pedmark Expansion for Cisplatin-Induced Hearing Loss Prevention

Reuters
·
Aug 18

Fennec Pharmaceuticals (FENC) Gets a Buy from Maxim Group

TIPRANKS
·
Aug 13

Fennec Pharmaceuticals is Maintained at Outperform by Wedbush

Dow Jones
·
Aug 13

Fennec Pharmaceuticals (FENC) Gets a Buy from Wedbush

TIPRANKS
·
Aug 12

B. Riley Adjusts Fennec Pharmaceuticals Price Target to $18 From $16, Maintains Buy Rating

MT Newswires Live
·
Aug 12

Canada's Cipher Pharma Q2 Revenue Falls on Lower Natroba Sales Amid Reduced Medicaid Coverage

Reuters
·
Aug 12

Aquestive Therapeutics Q2 Revenue Beats on Suboxone Strength

Reuters
·
Aug 12

Wedbush Adjusts Fennec Pharmaceuticals PT to $16 From $13, Maintains Outperform Rating

MT Newswires Live
·
Aug 11

Fennec Pharmaceuticals Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Fennec Pharmaceuticals Q2 Sales Rise on Pedmark Demand

Reuters
·
Aug 11

Fennec Pharmaceuticals Q2 EPS $0.05 Beats $0.02 Estimate, Sales $17.874M Beat $16.095M Estimate

Benzinga Earnings
·
Aug 11

Fennec Pharmaceuticals Q2 Product Sales USD 17.164 Million

THOMSON REUTERS
·
Aug 11

Fennec Pharmaceuticals Q2 EPS USD $0.05

THOMSON REUTERS
·
Aug 11

Fennec Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update

THOMSON REUTERS
·
Aug 11

Fennec Pharmaceuticals Inc. Expected to Post Earnings of 1 Cent a Share - Earnings Preview

Reuters
·
Aug 07

Fennec Pharmaceuticals Schedules Second-Quarter 2026 Results Call

Reuters
·
Aug 05

Fennec Pharmaceuticals Former Director Rosty Raykov Disposes of 10,000 Common Shares Worth $95,800

Reuters
·
Aug 05

Fennec Pharma Former Director Rosty Raykov Disposes of 9,599 Common Shares for $99,926.59

Reuters
·
Jul 03

Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
Jun 22

Fennec Pharmaceuticals shareholders elect directors at annual meeting

Reuters
·
Jun 15